Phospholipase D1 and choline kinase-α are interactive targets in breast cancer

References

• Glunde K, Bhujwalla ZM, Ronen SM. Choline metabolism in malignant transformation. Nat Rev Cancer 2011; 11:835 - 48; PMID: 22089420
   PubMed Web of Science ®Google Scholar
• Podo F. Tumour phospholipid metabolism. NMR Biomed 1999; 12:413 - 39; http://dx.doi.org/10.1002/(SICI)1099-1492(199911)12:7<413::AID-NBM587>3.0.CO;2-U; PMID: 10654290
   PubMed Web of Science ®Google Scholar
• Aboagye EO, Bhujwalla ZM. Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. Cancer Res 1999; 59:80 - 4; PMID: 9892190
   PubMed Web of Science ®Google Scholar
• Sitter B, Lundgren S, Bathen TF, Halgunset J, Fjosne HE, Gribbestad IS. Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters. NMR Biomed 2006; 19:30 - 40; http://dx.doi.org/10.1002/nbm.992; PMID: 16229059
   PubMed Web of Science ®Google Scholar
• Eliyahu G, Kreizman T, Degani H. Phosphocholine as a biomarker of breast cancer: molecular and biochemical studies. Int J Cancer 2007; 120:1721 - 30; http://dx.doi.org/10.1002/ijc.22293; PMID: 17236204
   PubMed Web of Science ®Google Scholar
• Sharma U, Baek HM, Su MY, Jagannathan NR. In vivo 1H MRS in the assessment of the therapeutic response of breast cancer patients. NMR Biomed 2011; 24:700 - 11; PMID: 21793075
   PubMed Web of Science ®Google Scholar
• Beloueche-Babari M, Arunan V, Troy H, te Poele RH, te Fong AC, Jackson LE, Payne GS, Griffiths JR, Judson IR, Workman P, et al. Histone deacetylase inhibition increases levels of choline kinase α and phosphocholine facilitating noninvasive imaging in human cancers. Cancer Res 2012; 72:990 - 1000; http://dx.doi.org/10.1158/0008-5472.CAN-11-2688; PMID: 22194463
   PubMed Web of Science ®Google Scholar
• Cai H, Erhardt P, Troppmair J, Diaz-Meco MT, Sithanandam G, Rapp UR, Moscat J, Cooper GM. Hydrolysis of phosphatidylcholine couples Ras to activation of Raf protein kinase during mitogenic signal transduction. Mol Cell Biol 1993; 13:7645 - 51; PMID: 8246981
   PubMed Web of Science ®Google Scholar
• Aoyama C, Liao H, Ishidate K. Structure and function of choline kinase isoforms in mammalian cells. Prog Lipid Res 2004; 43:266 - 81; http://dx.doi.org/10.1016/j.plipres.2003.12.001; PMID: 15003397
   PubMed Web of Science ®Google Scholar
• Gallego-Ortega D, Ramirez de Molina A, Ramos MA, Valdes-Mora F, Barderas MG, Sarmentero-Estrada J, Lacal JC. Differential role of human choline kinase alpha and beta enzymes in lipid metabolism: implications in cancer onset and treatment. PLoS One 2009; 4:e7819; http://dx.doi.org/10.1371/journal.pone.0007819; PMID: 19915674
   PubMed Web of Science ®Google Scholar
• Lacal JC. Choline kinase: a novel target for antitumor drugs. IDrugs 2001; 4:419 - 26; PMID: 16015482
   PubMedGoogle Scholar
• Ramírez de Molina A, Gutiérrez R, Ramos MA, Silva JM, Silva J, Bonilla F, Sánchez JJ, Lacal JC. Increased choline kinase activity in human breast carcinomas: clinical evidence for a potential novel antitumor strategy. Oncogene 2002; 21:4317 - 22; http://dx.doi.org/10.1038/sj.onc.1205556; PMID: 12082619
   PubMed Web of Science ®Google Scholar
• Ramírez de Molina A, Rodríguez-González A, Gutiérrez R, Martínez-Piñeiro L, Sánchez J, Bonilla F, Rosell R, Lacal J. Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers. Biochem Biophys Res Commun 2002; 296:580 - 3; http://dx.doi.org/10.1016/S0006-291X(02)00920-8; PMID: 12176020
   PubMed Web of Science ®Google Scholar
• Iorio E, Mezzanzanica D, Alberti P, Spadaro F, Ramoni C, D’Ascenzo S, Millimaggi D, Pavan A, Dolo V, Canevari S, et al. Alterations of choline phospholipid metabolism in ovarian tumor progression. Cancer Res 2005; 65:9369 - 76; http://dx.doi.org/10.1158/0008-5472.CAN-05-1146; PMID: 16230400
   PubMed Web of Science ®Google Scholar
• Ramírez de Molina A, Sarmentero-Estrada J, Belda-Iniesta C, Tarón M, Ramírez de Molina V, Cejas P, Skrzypski M, Gallego-Ortega D, de Castro J, Casado E, et al. Expression of choline kinase alpha to predict outcome in patients with early-stage non-small-cell lung cancer: a retrospective study. Lancet Oncol 2007; 8:889 - 97; http://dx.doi.org/10.1016/S1470-2045(07)70279-6; PMID: 17851129
   PubMed Web of Science ®Google Scholar
• Shah T, Wildes F, Penet MF, Winnard PT Jr., Glunde K, Artemov D, Ackerstaff E, Gimi B, Kakkad S, Raman V, et al. Choline kinase overexpression increases invasiveness and drug resistance of human breast cancer cells. NMR Biomed 2010; 23:633 - 42; http://dx.doi.org/10.1002/nbm.1510; PMID: 20623626
   PubMed Web of Science ®Google Scholar
• Glunde K, Raman V, Mori N, Bhujwalla ZM. RNA interference-mediated choline kinase suppression in breast cancer cells induces differentiation and reduces proliferation. Cancer Res 2005; 65:11034 - 43; http://dx.doi.org/10.1158/0008-5472.CAN-05-1807; PMID: 16322253
   PubMed Web of Science ®Google Scholar
• Su W, Chen Q, Frohman MA. Targeting phospholipase D with small-molecule inhibitors as a potential therapeutic approach for cancer metastasis. Future Oncol 2009; 5:1477 - 86; http://dx.doi.org/10.2217/fon.09.110; PMID: 19903073
   PubMed Web of Science ®Google Scholar
• McDermott M, Wakelam MJ, Morris AJ. Phospholipase D. Biochem Cell Biol 2004; 82:225 - 53; http://dx.doi.org/10.1139/o03-079; PMID: 15052340
   PubMed Web of Science ®Google Scholar
• Hammond SM, Altshuller YM, Sung TC, Rudge SA, Rose K, Engebrecht J, Morris AJ, Frohman MA. Human ADP-ribosylation factor-activated phosphatidylcholine-specific phospholipase D defines a new and highly conserved gene family. J Biol Chem 1995; 270:29640 - 3; http://dx.doi.org/10.1074/jbc.270.50.29640; PMID: 8530346
   PubMed Web of Science ®Google Scholar
• Hammond SM, Jenco JM, Nakashima S, Cadwallader K, Gu Q, Cook S, Nozawa Y, Prestwich GD, Frohman MA, Morris AJ. Characterization of two alternately spliced forms of phospholipase D1. Activation of the purified enzymes by phosphatidylinositol 4,5-bisphosphate, ADP-ribosylation factor, and Rho family monomeric GTP-binding proteins and protein kinase C-alpha. J Biol Chem 1997; 272:3860 - 8; http://dx.doi.org/10.1074/jbc.272.6.3860; PMID: 9013646
   PubMed Web of Science ®Google Scholar
• Steed PM, Clark KL, Boyar WC, Lasala DJ. Characterization of human PLD2 and the analysis of PLD isoform splice variants. FASEB J 1998; 12:1309 - 17; PMID: 9761774
   PubMed Web of Science ®Google Scholar
• Lee CS, Kim IS, Park JB, Lee MN, Lee HY, Suh PG, Ryu SH. The phox homology domain of phospholipase D activates dynamin GTPase activity and accelerates EGFR endocytosis. Nat Cell Biol 2006; 8:477 - 84; http://dx.doi.org/10.1038/ncb1401; PMID: 16622417
   PubMed Web of Science ®Google Scholar
• Bader MF, Vitale N. Phospholipase D in calcium-regulated exocytosis: lessons from chromaffin cells. Biochim Biophys Acta 2009; 1791:936 - 41; http://dx.doi.org/10.1016/j.bbalip.2009.02.016; PMID: 19289180
   PubMed Web of Science ®Google Scholar
• Mahankali M, Peng HJ, Cox D, Gomez-Cambronero J. The mechanism of cell membrane ruffling relies on a phospholipase D2 (PLD2), Grb2 and Rac2 association. Cell Signal 2011; 23:1291 - 8; http://dx.doi.org/10.1016/j.cellsig.2011.03.010; PMID: 21419846
   PubMed Web of Science ®Google Scholar
• Fang Y, Vilella-Bach M, Bachmann R, Flanigan A, Chen J. Phosphatidic acid-mediated mitogenic activation of mTOR signaling. Science 2001; 294:1942 - 5; http://dx.doi.org/10.1126/science.1066015; PMID: 11729323
   PubMed Web of Science ®Google Scholar
• Cockcroft S. Signalling roles of mammalian phospholipase D1 and D2. Cell Mol Life Sci 2001; 58:1674 - 87; http://dx.doi.org/10.1007/PL00000805; PMID: 11706993
   PubMed Web of Science ®Google Scholar
• Dhingra S, Rodriguez ME, Shen Q, Duan X, Stanton ML, Chen L, Zhang R, Brown RE. Constitutive activation with overexpression of the mTORC2-phospholipase D1 pathway in uterine leiomyosarcoma and STUMP: morphoproteomic analysis with therapeutic implications. Int J Clin Exp Pathol 2011; 4:134 - 46; PMID: 21326806
   PubMed Web of Science ®Google Scholar
• Shen Q, Stanton ML, Feng W, Rodriguez ME, Ramondetta L, Chen L, Brown RE, Duan X. Morphoproteomic analysis reveals an overexpressed and constitutively activated phospholipase D1-mTORC2 pathway in endometrial carcinoma. Int J Clin Exp Pathol 2010; 4:13 - 21; PMID: 21228924
   PubMed Web of Science ®Google Scholar
• Buchanan FG, McReynolds M, Couvillon A, Kam Y, Holla VR, Dubois RN, Exton JH. Requirement of phospholipase D1 activity in H-RasV12-induced transformation. Proc Natl Acad Sci U S A 2005; 102:1638 - 42; http://dx.doi.org/10.1073/pnas.0406698102; PMID: 15668389
   PubMed Web of Science ®Google Scholar
• Min DS, Kwon TK, Park WS, Chang JS, Park SK, Ahn BH, Ryoo ZY, Lee YH, Lee YS, Rhie DJ, et al. Neoplastic transformation and tumorigenesis associated with overexpression of phospholipase D isozymes in cultured murine fibroblasts. Carcinogenesis 2001; 22:1641 - 7; http://dx.doi.org/10.1093/carcin/22.10.1641; PMID: 11577003
   PubMed Web of Science ®Google Scholar
• Gozgit JM, Pentecost BT, Marconi SA, Ricketts-Loriaux RS, Otis CN, Arcaro KF. PLD1 is overexpressed in an ER-negative MCF-7 cell line variant and a subset of phospho-Akt-negative breast carcinomas. Br J Cancer 2007; 97:809 - 17; http://dx.doi.org/10.1038/sj.bjc.6603926; PMID: 17726467
   PubMed Web of Science ®Google Scholar
• Chen Y, Zheng Y, Foster DA. Phospholipase D confers rapamycin resistance in human breast cancer cells. Oncogene 2003; 22:3937 - 42; http://dx.doi.org/10.1038/sj.onc.1206565; PMID: 12813467
   PubMed Web of Science ®Google Scholar
• Kang DW, Park MH, Lee YJ, Kim HS, Lindsley CW, Alex Brown H, Min S. Autoregulation of phospholipase D activity is coupled to selective induction of phospholipase D1 expression to promote invasion of breast cancer cells. Int J Cancer 2011; 128:805 - 16; http://dx.doi.org/10.1002/ijc.25402; PMID: 20473892
   PubMed Web of Science ®Google Scholar
• Kang DW, Min S. Platelet derived growth factor increases phospholipase D1 but not phospholipase D2 expression via NFkappaB signaling pathway and enhances invasion of breast cancer cells. Cancer Lett 2010; 294:125 - 33; http://dx.doi.org/10.1016/j.canlet.2010.01.031; PMID: 20188462
   PubMed Web of Science ®Google Scholar
• Kang DW, Lee SH, Yoon JW, Park WS, Choi KY, Min S. Phospholipase D1 drives a positive feedback loop to reinforce the Wnt/beta-catenin/TCF signaling axis. Cancer Res 2010; 70:4233 - 42; http://dx.doi.org/10.1158/0008-5472.CAN-09-3470; PMID: 20442281
   PubMed Web of Science ®Google Scholar
• Zhong M, Shen Y, Zheng Y, Joseph T, Jackson D, Foster DA. Phospholipase D prevents apoptosis in v-Src-transformed rat fibroblasts and MDA-MB-231 breast cancer cells. Biochem Biophys Res Commun 2003; 302:615 - 9; http://dx.doi.org/10.1016/S0006-291X(03)00229-8; PMID: 12615079
   PubMed Web of Science ®Google Scholar
• Ramírez de Molina A, Báñez-Coronel M, Gutiérrez R, Rodríguez-González A, Olmeda D, Megías D, Lacal JC. Choline kinase activation is a critical requirement for the proliferation of primary human mammary epithelial cells and breast tumor progression. Cancer Res 2004; 64:6732 - 9; http://dx.doi.org/10.1158/0008-5472.CAN-04-0489; PMID: 15374991
   PubMed Web of Science ®Google Scholar
• Clem BF, Clem AL, Yalcin A, Goswami U, Arumugam S, Telang S, Trent JO, Chesney J. A novel small molecule antagonist of choline kinase-α that simultaneously suppresses MAPK and PI3K/AKT signaling. Oncogene 2011; 30:3370 - 80; http://dx.doi.org/10.1038/onc.2011.51; PMID: 21423211
   PubMed Web of Science ®Google Scholar
• Miyake T, Parsons SJ. Functional interactions between Choline kinase α, epidermal growth factor receptor and c-Src in breast cancer cell proliferation. Oncogene 2012; 31:1431 - 41; http://dx.doi.org/10.1038/onc.2011.332; PMID: 21822308
   PubMed Web of Science ®Google Scholar
• Bañez-Coronel M, Ramírez de Molina A, Rodríguez-González A, Sarmentero J, Ramos MA, García-Cabezas MA, García-Oroz L, Lacal JC. Choline kinase alpha depletion selectively kills tumoral cells. Curr Cancer Drug Targets 2008; 8:709 - 19; http://dx.doi.org/10.2174/156800908786733432; PMID: 19075594
   PubMed Web of Science ®Google Scholar
• Rodríguez-González A, Ramírez de Molina A, Bañez-Coronel M, Megias D, Lacal JC. Inhibition of choline kinase renders a highly selective cytotoxic effect in tumour cells through a mitochondrial independent mechanism. Int J Oncol 2005; 26:999 - 1008; PMID: 15753995
   PubMed Web of Science ®Google Scholar
• Warden CH, Friedkin M. Regulation of choline kinase activity and phosphatidylcholine biosynthesis by mitogenic growth factors in 3T3 fibroblasts. J Biol Chem 1985; 260:6006 - 11; PMID: 2987212
   PubMed Web of Science ®Google Scholar
• Paine TM, Soule HD, Pauley RJ, Dawson PJ. Characterization of epithelial phenotypes in mortal and immortal human breast cells. Int J Cancer 1992; 50:463 - 73; http://dx.doi.org/10.1002/ijc.2910500323; PMID: 1370949
   PubMed Web of Science ®Google Scholar
• Tyagi RK, Azrad A, Degani H, Salomon Y. Simultaneous extraction of cellular lipids and water-soluble metabolites: evaluation by NMR spectroscopy. Magn Reson Med 1996; 35:194 - 200; http://dx.doi.org/10.1002/mrm.1910350210; PMID: 8622583
   PubMed Web of Science ®Google Scholar